Natalie Sacks, Chief Medical Officer at Harpoon Therapeutics, Inc. (HARP), sold 11,652 shares at $13.17 ($153K) on 2019-11-01, disclosed to the SEC on 2019-11-05.
Open-market sale of $153k HARP by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.17 | 5,826 | $77K | 50.0% |
| 2 | $13.17 | 5,826 | $77K | 50.0% |
| Total | $13.17 avg | 11,652 | $153K | 100% |
| Filing → |
| HARP | SELL | 2020-04-17 | $18K | — | Filing → |
| HARP | SELL | 2020-04-15 | $110K | — | Filing → |
| HARP | SELL | 2020-04-08 | $15K | — | Filing → |